Abstract
Chronic pain affects millions of people every year. The recent focus on the opioid epidemic has brought substantial attention to the potential risks associated with opioid overprescribing. However, individuals who receive opioids differ in the extent to which they experience physiological dependence on opioids, engage in opioid misuse, or report symptoms of an opioid use disorder. Irrespective of the levels of opioid-related problems, there is a pressing need to develop and improve treatments for chronic pain and provide patients with greater access to pain interventions already known to be effective. The present chapter includes a concise overview of the literature on chronic pain treatment, with an emphasis on some of the consequences of, and alternatives to, opioid use. Non-opioid treatments for pain are described in detail as well as the extent to which these are supported by research. The underlying assumption of this chapter is that the current emphasis on reducing opioids provides a window of opportunity to critically evaluate the benefits and potential consequences of different pain treatments. However, even as researchers look for improved treatments, it is essential to continue to provide effective treatment to those with chronic pain – avoiding involuntary or rapid tapering of patients already receiving opioids and ensuring that high-risk groups, such as those with established substance use disorders, have access to effective pain treatments.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Murthy VH. Ending the opioid epidemic – a call to action. N Engl J Med. 2016;375(25):2413–5.
Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf. 2006;15(9):618–27.
Ciccarone D. Fentanyl in the US heroin supply: a rapidly changing risk environment. Int J Drug Policy. 2017;46:107–11.
Bohnert ASB, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA J Am Med Assoc. 2011;305(13):1315–21.
Rudd RA, et al. Increases in Drug and Opioid Overdose Deaths - United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016;64(50–51):1378–82.
Vivolo-Kantor AM, et al. Vital signs: trends in emergency department visits for suspected opioid overdoses – United States, July 2016–September 2017. MMWR Morb Mortal Wkly Rep. 2018;67(9):279–85.
Okie S. A flood of opioids, a rising tide of deaths. N Engl J Med. 2010;363(21):1981–5.
Institute of Medicine (US) Committee on Advancing Pain Research, Care, and Education. Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Mil Med. 2016;181(5):397–9.
Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the International Association for the Study of Pain, Subcommittee on Taxonomy. Pain Suppl. 1986;3:S1–226.
Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014;311(15):1547–55.
Phillips K, Clauw DJ. Central pain mechanisms in chronic pain states – maybe it is all in their head. Best Pract Res Clin Rheumatol. 2011;25(2):141–54.
Gaskin DJ, Richard P. The economic costs of pain in the United States. J Pain. 2012;13(8):715–24.
Rubin DI. Epidemiology and risk factors for spine pain. Neurol Clin. 2007;25(2):353–71.
Johannes CB, et al. The prevalence of chronic pain in United States adults: results of an Internet-based survey. J Pain. 2010;11(11):1230–9.
Tsang A, et al. Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders. J Pain. 2008;9(10):883–91.
Shmagel A, Foley R, Ibrahim H. Epidemiology of chronic low back pain in US Adults: data from the 2009-2010 National Health and Nutrition Examination Survey. Arthritis Care Res. 2016;68(11):1688–94.
Chou R, Shekelle P. Will this patient develop persistent disabling low back pain? JAMA J Am Med Assoc. 2010;303(13):1295–302.
Ahmedani BK, et al. Policies and events affecting prescription opioid use for non-cancer pain among an insured patient population. Pain Physician. 2014;17(3):205–16.
Porter J, Jick H. Addiction rare in patients treated with narcotics. N Engl J Med. 1980;302(2):123.
Portenoy RK, Foley KM. Chronic use of opioid analgesics in nonmalignant pain – report of 38 cases. Pain. 1986;25(2):171–86.
Chou R, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015;162(4):276–86.
Fishbain DA, et al. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med. 2008;9(4):444–59.
Edlund MJ, et al. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain. 2007;129(3):355–62.
Krebs EE, et al. Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain: the SPACE randomized clinical trial. JAMA. 2018;319(9):872–82.
Chou R, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113–30.
Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain – United States, 2016. MMWR Recomm Rep. 2016;65(1):1–49.
Ling W, Mooney L, Hillhouse M. Prescription opioid abuse, pain and addiction: clinical issues and implications. Drug Alcohol Rev. 2011;30(3):300–5.
Vowles KE, et al. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain. 2015;156(4):569–76.
Boyd CJ, McCabe SE. Coming to terms with the nonmedical use of prescription medications. Subst Abuse Treat Prev Policy. 2008;3:22.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
Kampman K, Jarvis M. American Society of Addiction Medicine (ASAM) National Practice Guideline for the use of medications in the treatment of addiction involving opioid use. J Addict Med. 2015;9(5):358–67.
Hauser W, et al. The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis. CNS Drugs. 2012;26(4):297–307.
Kroenke K, Krebs EE, Bair MJ. Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews. GenHospPsychiatry. 2009;31(3):206–19.
Krebs EE, et al. Treating the physical symptoms of depression with second-generation antidepressants: a systematic review and metaanalysis. Psychosomatics. 2008;49(3):191–8.
Lynch ME. Antidepressants as analgesics: a review of randomized controlled trials. J Psychiatry Neurosci. 2001;26(1):30–6.
Blondell RD, Azadfard M, Wisniewski AM. Pharmacologic therapy for acute pain. Am Fam Physician. 2013;87(11):766–72.
Tompkins DA, Hobelmann JG, Compton P. Providing chronic pain management in the “Fifth Vital Sign” era: historical and treatment perspectives on a modern-day medical dilemma. Drug Alcohol Depend. 2017;173(Suppl 1):S11–21.
Yarnitsky D, et al. Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy. Pain. 2012;153(6):1193–8.
Schmidt-Wilcke T, et al. Resting state connectivity correlates with drug and placebo response in fibromyalgia patients. Neuroimage Clin. 2014;6:252–61.
Lynch ME, Watson CP. The pharmacotherapy of chronic pain: a review. Pain Res Manag. 2006;11(1):11–38.
Attal N, Bouhassira D. Pharmacotherapy of neuropathic pain: which drugs, which treatment algorithms? Pain. 2015;156(Suppl 1):S104–14.
Staiger TO, et al. Systematic review of antidepressants in the treatment of chronic low back pain. Spine. 2003;28(22):2540–5.
Jann MW, Slade JH. Antidepressant agents for the treatment of chronic pain and depression. Pharmacotherapy. 2007;27(11):1571–87.
Riediger C, et al. Adverse effects of antidepressants for chronic pain: a systematic review and meta-analysis. Front Neurol. 2017;8:307.
Harris RE, et al. Pregabalin rectifies aberrant brain chemistry, connectivity, and functional response in chronic pain patients. Anesthesiology. 2013;119(6):1453–64.
Slavova S, et al. Prevalence of gabapentin in drug overdose postmortem toxicology testing results. Drug Alcohol Depend. 2018;186:80–5.
Gatchel RJ. Comorbidity of chronic pain and mental health disorders: the biopsychosocial perspective. Am Psychol. 2004;59(8):795–805.
Gatchel RJ, et al. Interdisciplinary chronic pain management: past, present, and future. Am Psychol. 2014;69(2):119–30.
Geisser ME, Roth RS, Williams DA. The allure of a cure. J Pain. 2006;7(11):797–9.
Bair MJ, et al. Depression and pain comorbidity – a literature review. Arch Intern Med. 2003;163(20):2433–45.
Fishbain DA, et al. Chronic pain-associated depression: antecedent or consequence of chronic pain? A review. Clin J Pain. 1997;13(2):116–37.
Casey CY, et al. Transition from acute to chronic pain and disability: a model including cognitive, affective, and trauma factors. Pain. 2008;134(1–2):69–79.
Brown GK. A causal analysis of chronic pain and depression. J Abnorm Psychol. 1990;99(2):127–37.
Gatzounis R, et al. Operant learning theory in pain and chronic pain rehabilitation. Curr Pain Headache Rep. 2012;16(2):117–26.
Lethem J, et al. Outline of a Fear-Avoidance Model of exaggerated pain perception--I. Behav Res Ther. 1983;21(4):401–8.
Williams AC, Eccleston C, Morley S. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev. 2012;11:CD007407.
Pincus T, McCracken LM. Psychological factors and treatment opportunities in low back pain. Best Pract Res Clin Rheumatol. 2013;27(5):625–35.
Hayes SC, et al. Acceptance and commitment therapy: model, processes and outcomes. Behav Res Ther. 2006;44(1):1–25.
Veehof MM, et al. Acceptance-based interventions for the treatment of chronic pain: a systematic review and meta-analysis. Pain. 2011;152(3):533–42.
Kabat-Zinn J. Mindfulness-based interventions in context: past, present, and future. Clin Psychol Sci Pract. 2003;10(2):144–56.
Kabat-Zinn J. An outpatient program in behavioral medicine for chronic pain patients based on the practice of mindfulness meditation: theoretical considerations and preliminary results. Gen Hosp Psychiatry. 1982;4(1):33–47.
Rosenzweig S, et al. Mindfulness-based stress reduction for chronic pain conditions: variation in treatment outcomes and role of home meditation practice. J Psychosom Res. 2010;68(1):29–36.
Cherkin DC, et al. Effect of mindfulness-based stress reduction vs cognitive behavioral therapy or usual care on back pain and functional limitations in adults with chronic low back pain: a randomized clinical trial. JAMA J Am Med Assoc. 2016;315(12):1240–9.
Gratzer D, Khalid-Khan F. Internet-delivered cognitive behavioural therapy in the treatment of psychiatric illness. Can Med Assoc J. 2016;188(4):263–72.
Brown M, et al. Effectiveness of web-delivered acceptance and commitment therapy in relation to mental health and well-being: a systematic review and meta-analysis. J Med Internet Res. 2016;18(8):e221.
Spijkerman MPJ, Pots WTM, Bohlmeijer ET. Effectiveness of online mindfulness-based interventions in improving mental health: a review and meta-analysis of randomised controlled trials. Clin Psychol Rev. 2016;45:102–14.
Carville SF, et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis. 2008;67(4):536–41.
Klement A, et al. Principles of treatment, coordination of medical care and patient education in fibromyalgia syndrome and chronic widespread pain. Schmerz. 2008;22(3):283–94.
Hayden JA, et al. Exercise therapy for treatment of non-specific low back pain. Cochrane Database Syst Rev. 2005;3:CD000335.
Busch AJ, Barber KA, Overend TJ, Peloso PMJ, Schachter CL. Exercise for treating fibromyalgia syndrome. Cochrane Database of Syst Rev. 2007;(4):CD003786. https://doi.org/10.1002/14651858.CD003786.pub2.
Valim V, et al. Aerobic fitness effects in fibromyalgia. J Rheumatol. 2003;30(5):1060–9.
Hassett AL, Williams DA. Non-pharmacological treatment of chronic widespread musculoskeletal pain. Best Pract Res Clin Rheumatol. 2011;25(2):299–309.
Feine JS, Lund JP. An assessment of the efficacy of physical therapy and physical modalities for the control of chronic musculoskeletal pain. Pain. 1997;71(1):5–23.
Deyle GD, et al. Physical therapy treatment effectiveness for osteoarthritis of the knee: a randomized comparison of supervised clinical exercise and manual therapy procedures versus a home exercise program. Phys Ther. 2005;85(12):1301–17.
Walker MJ, et al. The effectiveness of manual physical therapy and exercise for mechanical neck pain: a randomized clinical trial. Spine (Phila Pa 1976). 2008;33(22):2371–8.
Murthy V, Sibbritt DW, Adams J. An integrative review of complementary and alternative medicine use for back pain: a focus on prevalence, reasons for use, influential factors, self-perceived effectiveness, and communication. Spine J. 2015;15(8):1870–83.
Kessler RC, et al. Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med. 2001;135(4):262–8.
Witt C, et al. Acupuncture in patients with osteoarthritis of the knee: a randomised trial. Lancet. 2005;366(9480):136–43.
Ilgen MA, et al. Characteristics of adults seeking medical marijuana certification. Drug Alcohol Depend. 2013;132(3):654–9.
Lin LA, et al. Comparing adults who use cannabis medically with those who use recreationally: results from a national sample. Addict Behav. 2016;61:99–103.
Whiting PF, Wolff RF, Deshpande S. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA J Am Med Assoc. 2015;313(24):2456–73.
Nugent SM, Kansagara D. The effects of cannabis among adults with chronic pain. Ann Intern Med. 2018;168(7):525.
Boehnke KF, Litinas E, Clauw DJ. Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain. J Pain. 2016;17(6):739–44.
Vigil JM, et al. Associations between medical cannabis and prescription opioid use in chronic pain patients: a preliminary cohort study. PLoS One. 2017;12(11):e0187795.
Campbell G, et al. Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study. Lancet Public Health. 2018;3(7):e341–50.
Albert Einstein College of Medicine, I. MEMO-Medical Marijuana and Opioids Study [cited 14 Jan 2019]. Available from: https://clinicaltrials.gov/ct2/show/NCT03268551.
Degenhardt L, et al. The impact of cohort substance use upon likelihood of transitioning through stages of alcohol and cannabis use and use disorder: findings from the Australian National Survey on Mental Health and Wellbeing. Drug Alcohol Rev. 2018;37(4):546–56.
Ilgen MA, et al. The timing of onset of pain and substance use disorders. Am J Addict. 2010;19(5):409–15.
Potter JS, Prather K, Weiss RD. Physical pain and associated clinical characteristics in treatment-seeking patients in four substance use disorder treatment modalities. Am J Addict. 2008;17(2):121–5.
Ilgen MA, et al. A randomized trial of a pain management intervention for adults receiving substance use disorder treatment. Addiction. 2016;111(8):1385–93.
Rai A, et al. A review of adjunctive CNS medications used for the treatment of post-surgical pain. CNS Drugs. 2017;31(7):605–15.
Ajay Manhapra MD, Albert J, Arias MD, Jane C, Ballantyne MD. The conundrum of opioid tapering in long-term opioid therapy for chronic pain: a commentary. Subst Abus. 2018;39(2):152–61. https://doi.org/10.1080/08897077.2017.1381663.
Edlund MJ, et al. Patterns of opioid use for chronic noncancer pain in the Veterans Health Administration from 2009 to 2011. Pain. 2014;155(11):2337–43.
Lin LA, et al. Impact of the opioid safety initiative on opioid-related prescribing in veterans. Pain. 2017;158(5):833–9.
Darnall BD, et al. Patient-centered prescription opioid tapering in community outpatients with chronic pain. JAMA Intern Med. 2018;178(5):707–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Goesling, J., Ilgen, M. (2019). Effective Opioid Analgesic Alternatives and Approaches to Pain Management. In: Kelly, J., Wakeman, S. (eds) Treating Opioid Addiction. Current Clinical Psychiatry. Humana, Cham. https://doi.org/10.1007/978-3-030-16257-3_12
Download citation
DOI: https://doi.org/10.1007/978-3-030-16257-3_12
Published:
Publisher Name: Humana, Cham
Print ISBN: 978-3-030-16256-6
Online ISBN: 978-3-030-16257-3
eBook Packages: MedicineMedicine (R0)